Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Moser Matthias |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Bauernhofer, ET; Moser, T; Eberhard, A; Monsberger, N; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E
Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer
ANN ONCOL. 2025; 36: -ESMO Congress 2025; OCT 17-21, 2025; Berlin, GERMANY.
Doi: 10.1016/j.annonc.2025.08.3135
[Poster]
Web of Science
FullText
FullText_MUG
Moser, T; Bauernhofer, E; Eberhard, A; Monsberger, N; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E
Beyond Blood? Assessing the prognostic and complementary role of urinary ctDNA in metastatic prostate cancer.
7th Advances in Circulating Tumor Cells meeting: “Liquid Biopsy: from Bench to Bedside”. 2025; -ACTC; SEP 24-27, 2025; Thessaloniki, GREECE.
[Poster]
Moser, T; Bauernhofer, E; Eberhard, A; Monsberger, N; Vlachos, G; Moser, MJ; Glawitsch, L; Hammer, S; Ziegler, L; Geigl, JB; Bauernhofer, T; Heitzer, E
Beyond Blood: Can Urinary ctDNA Expand the Diagnostic Window in Advanced Prostate Cancer?
14th International Symposium on Circulating Nucleic Acids in Plasma and Serum. 2025; -CNAPS; DEC 3-5, 2025; Hong Kong, CHINA.
[Poster]
Vlachos, G; Moser, T; Lazzeri, I; Moser, MJ; Bauernhofer, ET; Eberhard, A; Blatterer, J; Kühberger, S; Monsberger, N; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E
Multimodal cfDNA profiling reveals functional homologous recombination deficiency in prostate cancer.
Advances in Circulating Tumor Cells (ACTC); SEP 24-27, 2025; Thessaloniki, GREECE. 2025.
[Oral Communication]
Vlachos, G; Sadeghi, H; Moser, T; Lazzeri, I; Moser, MJ; Glawitsch, L; Bauernhofer, ET; Eberhard, A; Beichler, C; Blatterer, J; Kühberger, S; Monsberger, N; Terbuch, A; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E
Functional Homologous Recombination Deficiency in Prostate Cancer Revealed Through Multimodal cfDNA Profiling.
14th CNAPS International Symposium, Hong Kong. 2025; -14th CNAPS International Symposium (CNAPS 2025); DEC 3-5, 2025; Hong Kong, CHINA.
[Poster]
Moser, MJ
Cancer monitoring via blood.
Cancer Research Day; OCT 16, 2024; Graz, AUSTRIA. 2024.
[Oral Communication]
Moser, MJ; Moser, T; Heitzer E
Mathematical approaches boost circulating tumor DNA detection via fragmentomics.
EACR - Liquid Biopsies; NOV 12-14, 2024; Lyon, FRANCE. 2024.
[Poster]
Moser, T; Eberhard, A; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Lazzeri, I; Ziegler, L; Bauernhofer, E; Monsberger N; Geigl, JB; Bauernhofer, T; Heitzer, E
Linking liquids: cfDNA in urine and plasma as informative allies in metastasized prostate cancer.
Annual Meeting 2024. 2024; -AACR; APR 5-10, 2024; San Diego, USA.
[Poster]
FullText
Moser, T; Moser, MJ; Eberhard, A; Ziegler, L; Bauernhofer, T; Heitzer E
Fragmentomics in focus: how urine collection shapes liquid biopsy analysis.
EACR - Liquid Biopsies; NOV 12-14, 2024; Lyon, FRANCE. 2024.
[Poster]
Moser, T; Moser; MJ; Heitzer, E
Cancer monitoring via blood.
Servier Seedpods Day; JUN 29, 2023; Paris-Saclay, FRANCE. 2023.
[Oral Communication]
Moser, T; Moser, MJ; Lockhart, Brian; Guigal-Stephan, Nolwen; Speicher, MR; Heitzer, E
It’s in our blood: Monitoring cancer treatment via circulating DNA fragmentomics.
Servier Seedpods Day; JUN 29, 2023; Paris-Saclay, FRANCE. 2023.
[Poster]